The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2,3-dichlorophenyl)-3,7-dihydroxy-8-(pyrrolidin-1-ylmethyl)-4H-chromen-4-one ID: ALA4874187
PubChem CID: 164627580
Max Phase: Preclinical
Molecular Formula: C20H17Cl2NO4
Molecular Weight: 406.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1c(O)c(-c2cccc(Cl)c2Cl)oc2c(CN3CCCC3)c(O)ccc12
Standard InChI: InChI=1S/C20H17Cl2NO4/c21-14-5-3-4-11(16(14)22)20-18(26)17(25)12-6-7-15(24)13(19(12)27-20)10-23-8-1-2-9-23/h3-7,24,26H,1-2,8-10H2
Standard InChI Key: DKMZIRVPLSULTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
20.7503 -23.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7491 -24.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4572 -24.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4554 -22.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0425 -22.9640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4530 -22.1464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7440 -21.7399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1640 -23.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1629 -24.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8691 -24.5986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5809 -24.1915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5821 -23.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8714 -22.9573 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8668 -25.4157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2875 -24.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2889 -22.9669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9960 -23.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7042 -22.9727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7066 -22.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9949 -21.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2896 -22.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5817 -21.7447 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.9940 -20.9273 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.6543 -20.9284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8544 -20.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4479 -21.4698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9966 -22.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 9 2 0
8 4 2 0
4 1 1 0
1 5 1 0
4 6 1 0
6 7 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
10 14 2 0
11 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
12 16 1 0
21 22 1 0
20 23 1 0
7 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 7 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.27Molecular Weight (Monoisotopic): 405.0535AlogP: 4.77#Rotatable Bonds: 3Polar Surface Area: 73.91Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.16CX Basic pKa: 8.05CX LogP: 2.63CX LogD: 2.59Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.11
References 1. Hou Y, Kuang W, Min W, Liu Z, Zhang F, Yuan K, Wang X, Sun C, Cheng H, Wang L, Xiao Y, Pu S, Xin GZ, Yang P.. (2021) Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment., 64 (20.0): [PMID:34644502 ] [10.1021/acs.jmedchem.1c00087 ]